GEP20257808B - Immunogenic compositions against enteric diseases and methods for its preparation thereof - Google Patents
Immunogenic compositions against enteric diseases and methods for its preparation thereofInfo
- Publication number
- GEP20257808B GEP20257808B GEAP202015919A GEAP2020015919A GEP20257808B GE P20257808 B GEP20257808 B GE P20257808B GE AP202015919 A GEAP202015919 A GE AP202015919A GE AP2020015919 A GEAP2020015919 A GE AP2020015919A GE P20257808 B GEP20257808 B GE P20257808B
- Authority
- GE
- Georgia
- Prior art keywords
- preparation
- methods
- immunogenic compositions
- compositions against
- enteric diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921035435 | 2019-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP20257808B true GEP20257808B (en) | 2025-10-27 |
Family
ID=72659843
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP202015919A GEP20257808B (en) | 2019-09-03 | 2020-09-02 | Immunogenic compositions against enteric diseases and methods for its preparation thereof |
| GEAP202515919A GEAP202515919A (en) | 2019-09-03 | 2020-09-02 | Immunogenic compositions against enteric diseases and methods for its preparation thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP202515919A GEAP202515919A (en) | 2019-09-03 | 2020-09-02 | Immunogenic compositions against enteric diseases and methods for its preparation thereof |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20230149524A1 (https=) |
| EP (2) | EP4249061A3 (https=) |
| JP (2) | JP7732974B2 (https=) |
| KR (2) | KR20240155975A (https=) |
| CN (1) | CN114728053A (https=) |
| AR (1) | AR119884A1 (https=) |
| AU (1) | AU2020343943A1 (https=) |
| BR (1) | BR112022003892A2 (https=) |
| CA (1) | CA3149972A1 (https=) |
| CO (1) | CO2022003789A2 (https=) |
| CR (1) | CR20220132A (https=) |
| EC (1) | ECSP22031077A (https=) |
| GB (2) | GB2603362B (https=) |
| GE (2) | GEP20257808B (https=) |
| IL (1) | IL291006B2 (https=) |
| JO (1) | JOP20200214A1 (https=) |
| MA (1) | MA56283A1 (https=) |
| MX (1) | MX2022002693A (https=) |
| PE (1) | PE20221442A1 (https=) |
| PH (1) | PH12022550525A1 (https=) |
| PY (1) | PY2051122A (https=) |
| WO (1) | WO2021044436A2 (https=) |
| ZA (1) | ZA202203368B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121569027A (zh) * | 2023-07-21 | 2026-02-24 | 葛兰素史克生物有限公司 | 免疫原性组合物 |
| WO2025217253A1 (en) * | 2024-04-12 | 2025-10-16 | Neogen Corporation | Neutralizing compositions and related methods |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4057685A (en) | 1972-02-02 | 1977-11-08 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4459286A (en) | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
| AU1420897A (en) * | 1996-12-18 | 1998-07-15 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Conjugate vaccine for (salmonella paratyphi) a |
| DE69941574D1 (de) | 1998-08-19 | 2009-12-03 | Baxter Healthcare Sa | Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid |
| US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| PE20110072A1 (es) | 2005-06-27 | 2011-02-04 | Glaxosmithkline Biolog Sa | Composicion inmunogenica |
| AU2007294731B2 (en) | 2006-09-13 | 2014-04-17 | Abbvie Inc. | Cell culture improvements |
| GB0700135D0 (en) * | 2007-01-04 | 2007-02-14 | Glaxosmithkline Biolog Sa | Vaccine |
| FR2938265B1 (fr) | 2008-11-12 | 2011-07-15 | Univ Claude Bernard Lyon | Procede pour le pilotage d'un traitement de depolymerisation par ultrasons d'un biopolymere hydrosoluble |
| CA2836153C (en) * | 2009-12-17 | 2016-06-21 | Fina Biosolutions, Llc | Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| US9011871B2 (en) * | 2011-11-07 | 2015-04-21 | University Of Maryland, Baltimore | Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease |
| IN2012MU00206A (https=) * | 2012-01-20 | 2013-08-09 | ||
| MX354103B (es) | 2012-01-30 | 2018-02-13 | Serum Inst India Ltd | Composicion inmunogenica. |
| CN102935226B (zh) * | 2012-11-16 | 2014-01-22 | 罗益（无锡）生物制药有限公司 | 伤寒甲型副伤寒结合疫苗及其制备方法 |
| KR102447303B1 (ko) * | 2013-08-24 | 2022-09-23 | 브하라트 바이오테크 인터내셔날 리미티드 | 박테리아성 백신 및 그의 제조방법 |
| CN104383532A (zh) * | 2014-12-02 | 2015-03-04 | 云南沃森生物技术股份有限公司 | 一种用乙肝表面抗原为载体蛋白的细菌多糖蛋白结合物疫苗及其制备方法 |
| CN104587461A (zh) * | 2015-01-05 | 2015-05-06 | 云南沃森生物技术股份有限公司 | 伤寒、甲型乙型副伤寒多糖蛋白结合型多价联合疫苗 |
| WO2017006349A1 (en) * | 2015-07-04 | 2017-01-12 | Bharat Biotech International Limited | Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides |
| US20190134177A1 (en) * | 2016-04-25 | 2019-05-09 | National Institute Of Immunology | Conjugate for vaccination against typhoid comprising chemical conjugate of vi polysaccharide and flagellin, a process for producing the same and a composition comprising the conjugate |
| MY191163A (en) | 2016-08-26 | 2022-06-03 | The Centers For Disease Control And Prevention Cdc | Multivalent vaccine composition |
| US11739356B2 (en) * | 2017-05-05 | 2023-08-29 | Serum Institute Of India Private Limited | Method for removal of impurities from bacterial capsular polysaccharide based preparations |
| CN111032078A (zh) | 2017-07-18 | 2020-04-17 | 血清研究所印度私人有限公司 | 具有改善的稳定性、增强的免疫原性和降低的反应原性的免疫原性组合物及其制备方法 |
| EA202190778A1 (ru) | 2018-10-12 | 2021-08-05 | Серум Инститьют Оф Индия Прайват Лтд | Композиция комбинированной вакцины, содержащая уменьшенную дозу инактивированного полиовируса, и способ её получения |
| MX2021005500A (es) * | 2018-11-10 | 2021-09-08 | Bharat Biotech Int Ltd | Composiciones inmunogenicas de glicoconjugados multivalentes. |
-
2019
- 2019-09-03 JO JOP/2020/0214A patent/JOP20200214A1/ar unknown
-
2020
- 2020-09-02 GB GB2204276.6A patent/GB2603362B/en active Active
- 2020-09-02 BR BR112022003892A patent/BR112022003892A2/pt unknown
- 2020-09-02 WO PCT/IN2020/050763 patent/WO2021044436A2/en not_active Ceased
- 2020-09-02 IL IL291006A patent/IL291006B2/en unknown
- 2020-09-02 EP EP23184552.0A patent/EP4249061A3/en active Pending
- 2020-09-02 JP JP2022514468A patent/JP7732974B2/ja active Active
- 2020-09-02 PE PE2022000363A patent/PE20221442A1/es unknown
- 2020-09-02 AU AU2020343943A patent/AU2020343943A1/en active Pending
- 2020-09-02 MX MX2022002693A patent/MX2022002693A/es unknown
- 2020-09-02 GE GEAP202015919A patent/GEP20257808B/en unknown
- 2020-09-02 CA CA3149972A patent/CA3149972A1/en active Pending
- 2020-09-02 GE GEAP202515919A patent/GEAP202515919A/en unknown
- 2020-09-02 PH PH1/2022/550525A patent/PH12022550525A1/en unknown
- 2020-09-02 MA MA56283A patent/MA56283A1/fr unknown
- 2020-09-02 GB GB2412329.1A patent/GB2629746B/en active Active
- 2020-09-02 KR KR1020247034650A patent/KR20240155975A/ko active Pending
- 2020-09-02 CN CN202080074655.7A patent/CN114728053A/zh active Pending
- 2020-09-02 US US17/753,248 patent/US20230149524A1/en active Pending
- 2020-09-02 CR CR20220132A patent/CR20220132A/es unknown
- 2020-09-02 KR KR1020227011108A patent/KR20220087437A/ko active Pending
- 2020-09-02 EP EP20781107.6A patent/EP4025246A2/en active Pending
- 2020-09-03 PY PY202002051122A patent/PY2051122A/es unknown
- 2020-09-03 AR ARP200102458A patent/AR119884A1/es unknown
-
2022
- 2022-03-22 ZA ZA2022/03368A patent/ZA202203368B/en unknown
- 2022-03-29 CO CONC2022/0003789A patent/CO2022003789A2/es unknown
- 2022-04-01 EC ECSENADI202231077A patent/ECSP22031077A/es unknown
-
2024
- 2024-09-18 JP JP2024160658A patent/JP2024178271A/ja active Pending
- 2024-10-21 US US18/921,691 patent/US20250134980A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019501552A1 (en) | Polypeptide-antigen conjugates with non-natural amino acids | |
| ZA201901170B (en) | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates | |
| PH12015500633A1 (en) | Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor | |
| GB201101665D0 (en) | Immunogenic compositions | |
| PH12017501898A1 (en) | Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | |
| NZ601538A (en) | Vaccine compositions comprising a mutated factor h binding protein | |
| NZ622048A (en) | Hybrid polypeptides including meningococcal fhbp sequences | |
| SG178595A1 (en) | Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity | |
| NZ628449A (en) | Neisseria meningitidis compositions and methods thereof | |
| MX2021014710A (es) | Un conjugado inmunogenico de polisacarido de neumococo del serotipo 35b- proteina y proceso de conjugacion para preparar el mismo. | |
| PH12016500360A1 (en) | A bacterial vaccine and methods for manufacture thereof | |
| EA201692279A1 (ru) | Способ уменьшения иммуногенности белка и пептида | |
| GEAP202515919A (en) | Immunogenic compositions against enteric diseases and methods for its preparation thereof | |
| EA201800067A1 (ru) | Полисахаридные вакцинные препараты и способ промышленного получения бактериальных полисахаридов | |
| AU2018347511A8 (en) | Periodontitis vaccine and related compositions and method of use | |
| WO2023235660A3 (en) | Flavivirus immunogens and vaccine compositions and methods of using the same | |
| NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella | |
| CN106798919A (zh) | 一种山羊免疫方法 | |
| EP4509185A3 (en) | Methods of enhancing immunogenicity of poorly immunogenic antigen-specific vaccines using oral yeast beta-glucans | |
| MX349930B (es) | Composiciones inmunogenas. | |
| RU2636454C2 (ru) | Вакцина для профилактики некробактериоза животных и способ её получения | |
| EA201991559A1 (ru) | Конъюгаты полипептид-антиген с неприродными аминокислотами | |
| RO132029A8 (ro) | Producerea şi utilizarea pulberii din membrana cochilieră a oului hiperimun hpc2 | |
| UA98958U (ru) | Способ повышения иммунной реактивности и коррекции стрессового состояния кроликов перед забоем | |
| UA98752U (ru) | Способ повышения иммунной реактивности и коррекция стрессового состояния птицы перед убоем |